Vasopeptidase inhibitors and their potential role in diabetes.
Chowdhury
T A
TA
Department of Medicine, Central Middlesex Hospital, London, UK. Tasheen.Chowdhury@nwlh.nhs.uk
Khan
T
T
D000959:Antihypertensive Agents / Q000145:classification / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology*; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D011725:Pyridines / Q000627:therapeutic use; D012084:Renin-Angiotensin System / Q000187:drug effects / Q000502:physiology; D013841:Thiazepines / Q000627:therapeutic use
D000959:Antihypertensive Agents; D002317:Cardiovascular Agents; D011725:Pyridines; D013841:Thiazepines; C106266:omapatrilat